Preliminary quarterly sales figures for Vykat surpassed Wall Street estimates, but shares fell on concerns the company may ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Next month will be the first opportunity to gauge the commercial launch of a new treatment for Prader-Willi syndrome, a rare ...

Soleno Therapeutics's previously-announced public offering of 2.35 million shares was priced at $85 apiece, resulting in $200 million in proceeds. The biopharmaceutical company said on Thursday that ...

Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Katie Price, previously also known as Jordan, has this week opened up about her eldest son Harvey - whom she shares with ...

Aardvark's lead drug ARD-101 targets PWS and HO with trials underway and funding secured through 2027 after a $94.2 million ...

Speaking in a recent podcast episode, Katie Price revealed that a "lot's gonna change" for her son, Harvey, who is set to ...

ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...